Skip to main content
. 2017 Jan 1;7(1):213–227. doi: 10.7150/thno.16044

Figure 10.

Figure 10

Evaluation of the diagnostic performance of lncRNA-based Index I in the external phase. (A) The ability of the lncRNA-based panel to differentiate patients with GC and individuals with precancerous lesions (Prec). (B) The ability of the lncRNA-based panel to differentiate patients with GC and individuals with gastrointestinal stromal tumor (GIST).